-
AHCA Secretary Jason Weida told a state House panel he is “cautiously optimistic” the FDA will approve the plan, which the state has been pursuing since 2019.
-
Colorado officials say they haven’t been able to stand up a program to import drugs from Canada because of drugmaker opposition — and the Biden administration’s inaction.
-
The FDA and the manufacturer were alerted to Profemur titanium hips breaking inside patients as of 2005. It took 15 years to recall the devices. Many fractures could have been avoided.
-
The surgical drug is being prescribed as a psychedelic therapy for an array of unapproved uses, including depression and anxiety. Behind the trend are investors setting up for-profit clinics.
-
Probiotics, which supplement regular feeding and contain live organisms such as bacteria or yeast, can lead to invasive, potentially fatal infections or disease, the FDA said.
-
The FDA had been expected to decide by next week, but a back-and-forth between state and federal officials about details of the proposal means the wait will continue, a court document says.
-
Prosecutors said the Bradenton family's Genesis II Church of Health and Healing sold $1 million worth of their so-called Miracle Mineral Solution. What they were selling was actually chlorine dioxide, which can be fatal when ingested.
-
If the DEA decides to reclassify marijuana to Schedule III, it wouldn't legalize recreational use nationwide. But it would have some impact, particularly on research and pot business taxes.
-
With a decision expected this fall on whether Florida can import cost-saving drugs, the state lashed out after federal officials raised issues such as a requirement for a secured warehouse in Michigan.
-
The state alleges the federal agency violated the Freedom of Information Act. The revised lawsuit includes allegations that the FDA did not properly respond to a records request submitted in May.
-
A tornado that tore through eastern North Carolina and struck a large Pfizer pharmaceutical plant has damaged its drug storage facility but not its medicine production areas.
-
Minorities tend to be diagnosed at later stages of the disease, which would exclude them from use of Leqembi. Few Black people were included in the main trial of the drug.